Newsletter

290650 - L & C BIO Co., Ltd.

290650 Summary
Biopharma
Stock Price & Overview
₩52,500 +1,900 (+3.75%) Close · Sep 9, 2026 KST
KOSDAQ | ₩KRW | Close: ₩52,500  ≈ US$38  ·  Market cap ₩1.4tn (≈ $1.0bn)
Home › 290650 › Filings

5% Ownership Report — Large Holdings

DART
L & C BIO Co., Ltd.
Filed Sep 9, 2026 KST · Ownership · receipt 20260909000491

kstock has not written this one up. The title above is a translation of the Korean form name; the filing itself is on DART, in Korean.

Read the original on DART ↗ Korean. DART is Korea's electronic disclosure system, run by the Financial Supervisory Service — the filing equivalent of EDGAR.
Korean form name: 주식등의대량보유상황보고서(일반)

290650

Price
₩52,500
Change
+3.75%
Market cap
₩1.4tn
Prev. close
₩50,600
290650 SummaryCompare to Peers

290650 data on kstock

Financials
11 fiscal years

Every figure is taken from L & C BIO Co., Ltd.'s own DART filings and matched on IFRS account codes, so a line holds across years where the Korean wording changed.

More 290650 filings

Ex-rights

09/02/26

Prospectus

09/02/26

Securities registration statement (equity securities)

09/02/26

Paid-in and bonus share issue

09/02/26

Rights offering: first issue price determined

09/02/26

Notice that the registration statement has taken effect

09/02/26
All 290650 filings